Dose Response of Exercise for Arthritis Management
Launched by UNIVERSITY OF SOUTH CAROLINA · Mar 11, 2025
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Dose Response of Exercise for Arthritis Management," is studying how different amounts of physical activity can help manage symptoms of arthritis and related conditions, such as rheumatoid arthritis, gout, and fibromyalgia. The researchers want to find out if exercising for 45 minutes, 90 minutes, or 150 minutes each week makes a difference in how people feel and function. The study is currently looking for participants who are 18 years or older, have been diagnosed with a form of arthritis, and can read and write in English.
If you decide to join this trial, you'll be randomly assigned to one of the three exercise groups. It’s important to note that you cannot already be exercising for more than 30 minutes a week or have certain health issues that could make exercise unsafe. Participants will need to use a Fitbit device to track their activity. Overall, this study aims to provide valuable information about how exercise can benefit those living with arthritis, and your involvement could help others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Have a doctor diagnosed form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia
- • Ability to read and write in English
- Exclusion Criteria:
- • Have any contraindications to exercise (besides arthritis)
- • Engage in ≥30 min/week of Actigraph assessed MVPA
- • Are pregnant, breastfeeding, or planning to become pregnant in the next year
- • Are planning to relocate out of the Columbia, SC area in the next 12 months,
- • Do not have a device compatible with Fitbit
- • Have uncontrolled hypertension (e.g., systolic blood pressure \> 160 mmHg or diastolic blood pressure \> 100 mmHg)
- • Plan to have a surgery that affects mobility in the next 12 months
- • Have a serious cognitive impairment.
- • Not willing to be randomized to any of the 3 conditions, do not believe they could adhere to the goals, or do not believe they could achieve the highest dose of activity (150 minutes/week).
About University Of South Carolina
The University of South Carolina (USC) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a commitment to excellence in research and education, USC leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical investigations aimed at improving patient outcomes and addressing pressing health challenges. Collaborating with a diverse network of healthcare professionals, researchers, and community partners, USC fosters an environment of discovery and translation, ensuring that findings from clinical trials contribute significantly to the advancement of medical science and evidence-based practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, South Carolina, United States
Patients applied
Trial Officials
Christine Pellegrini, PhD
Principal Investigator
University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported